950210 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Prestige BioPharma Ltd. engages in the development and commercialization of biosimilars and antibody therapeutics. The firm develops antibody drugs for solid tumor, pancreatic cancer, and arthritis. Its product portfolio includes Herceptin, Avastin, and Humira biosimilars as well as anti-PAUF and anti-CTHRC1 antibodies. The company was founded in July 2005 and is headquartered in Singapore.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
950210 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company